Date: September 25-26, 2019
Organised by: ISPE
Biopharmaceuticals have become a main pillar in the pharmaceutical industry, with significant transformation in the development, strategy, technology and operations. This transformation is a continuous process, which is impacted by other developments in digitalization amongst other factors.
Entirely new concepts, such as gene – and cell therapy, are being brought to market, which offers even more possibilities to regenerative medicine or disease remission. However, there are still operational and technological challenges.
During these 2 days- event, there will be different tracks:
Track 1: Gene & Cell Therapy Discuss the evolving landscape with topics ranging from regulatory updates, design, and operation, automation strategies, and commercial launch of ATMP facilities and products
Track 2: Regulatory & Quality Leading experts from WHO, Bayer, Novartis, and more will share their insights and thoughts on GMP for biologicals, Annex 1, patient-specific specifications, and advanced therapy medicinal (ATMP) products
Track 3: Digitisation & ISPE Pharma 4.0 Glimpse into a broad and diverse spectrum of a new world of technologies starting from data monitoring to new therapeutic modalities
Track 4: Operational Innovation in Biotechnology Get sustainable ways to get ahead–and stay ahead, including cultural innovations in project and portfolio management, automation after an M&E, leveraging workforce 4.0
The 2019 ISPE Europe Biotechnology Conference will address these topics with industry case studies and plant tours.
It’ s our first participation to this event and we’re looking forward to meeting you!
Fore more info and registration: https://ispe.org/conferences/2019-europe-biotechnology